OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
- Conditions
- Behavioral SymptomsAutistic Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-06-16
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 218
- Registration Number
- NCT00337571
- Locations
- 🇺🇸
Cambridge Health Alliance, Medford, Massachusetts, United States
🇺🇸Clinical Innovations, Inc., Huntington Beach, California, United States
🇺🇸University Of Florida, Gainesville, Florida, United States
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
- First Posted Date
- 2006-06-01
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 98
- Registration Number
- NCT00332241
- Locations
- 🇺🇸
Univ Of Nc, Chapel Hill, North Carolina, United States
🇺🇸Neurobehavioral Medicine Group, Bloomfield Hills, Michigan, United States
🇺🇸Marsella, Gregory, Boca Raton, Florida, United States
Effect on Cognitive Function of a Treatment With Aripiprazole
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 500
- Registration Number
- NCT00329810
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- First Posted Date
- 2006-05-15
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 323
- Registration Number
- NCT00325689
- Locations
- 🇺🇸
Atp Clinical Research, Inc., Costa Mesa, California, United States
🇺🇸J. Gary Booker, Md, Shreveport, Louisiana, United States
🇺🇸Sheppard Pratt Health System, Baltimore, Maryland, United States
Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 20
- Registration Number
- NCT00321516
- Locations
- 🇺🇸
Local Institution, Desota, Texas, United States
A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
- First Posted Date
- 2006-03-10
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 200
- Registration Number
- NCT00300846
- Locations
- 🇬🇧
Local Institution, London, United Kingdom
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
- Conditions
- Schizophrenia and Schizoaffective Disorder
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 400
- Registration Number
- NCT00292409
A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
- Conditions
- Bipolar Disorder
- Interventions
- First Posted Date
- 2006-01-16
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 1169
- Registration Number
- NCT00277212
- Locations
- 🇺🇸
Sheppard Pratt Health System, Baltimore, Maryland, United States
🇺🇸Neuro Behavioral Clinical Research, Inc., Canton, Ohio, United States
🇺🇸Belmont Center For Comprehensive Treatment, Philadelphia, Pennsylvania, United States
A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
- Conditions
- Bipolar Disorder
- Interventions
- Drug: Lithium or Valproate with AripiprazoleDrug: Lithium or Valproate with placebo (PBO)
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2023-04-18
- Target Recruit Count
- 1270
- Registration Number
- NCT00261443
- Locations
- 🇺🇸
Us Clinical Research Centers, Llc, Costa Mesa, California, United States
🇺🇸Cns Research Institute, P.C., Clementon, New Jersey, United States
🇺🇸University Of South Florida, Tampa, Florida, United States
Study of Aripiprazole in Patients With Bipolar I Disorder
- Conditions
- Bipolar Disorder
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 400
- Registration Number
- NCT00257972
- Locations
- 🇬🇧
Local Institution, Surbiton, Middlesex, United Kingdom